Optimal Regimens and Clinical Breakpoint of Avilamycin Against Clostridium perfringens in Swine Based on PK-PD Study
Clostridium perfringens causes significant morbidity and mortality in swine worldwide. Avilamycin showed no cross resistance and good activity for treatment of C. perfringens. The aim of this study was to formulate optimal regimens of avilamycin treatment for C. perfringens infection based on the cl...
Main Authors: | Anxiong Huang, Xun Luo, Zihui Xu, Lingli Huang, Xu Wang, Shuyu Xie, Yuanhu Pan, Shiwei Fang, Zhenli Liu, Zonghui Yuan, Haihong Hao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.769539/full |
Similar Items
-
Exploration of Clinical Breakpoint of Danofloxacin for <i>Glaesserella parasuis</i> in Plasma and in PELF
by: Zihui Xu, et al.
Published: (2021-07-01) -
Prudent Use of Tylosin for Treatment of Mycoplasma gallisepticum Based on Its Clinical Breakpoint and Lung Microbiota Shift
by: Anxiong Huang, et al.
Published: (2021-09-01) -
Rational Use of Danofloxacin for Treatment of <i>Mycoplasma gallisepticum</i> in Chickens Based on the Clinical Breakpoint and Lung Microbiota Shift
by: Shuge Wang, et al.
Published: (2022-03-01) -
Evidence for Establishing the Clinical Breakpoint of Cefquinome against Haemophilus Parasuis in China
by: Kun Mi, et al.
Published: (2021-01-01) -
Determination of Susceptibility Breakpoint for Cefquinome against <i>Streptococcus suis</i> in Pigs
by: Kun Mi, et al.
Published: (2021-08-01)